<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Sonali</First><Last>Arora</Last></Person>
    <Email>sarora@fredhutch.org</Email>
    <Organization>FHCRC</Organization>
    <Address>
      <Line>1100 Fairview Ave N,</Line>
      <City>Seattle</City>
      <State>WA</State>
      <Zip-Code>98109</Zip-Code>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Organization>GEO</Organization>
    <Address>
      <City></City>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Yiting</First><Last>Lim</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Andrew</First><Middle>C</Middle><Last>Hsieh</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL16791">
    <Status database="GEO">
      <Submission-Date>2013-03-14</Submission-Date>
      <Release-Date>2013-03-14</Release-Date>
      <Last-Update-Date>2019-03-27</Last-Update-Date>
    </Status>
    <Title>Illumina HiSeq 2500 (Homo sapiens)</Title>
    <Accession database="GEO">GPL16791</Accession>
    <Technology>high-throughput sequencing</Technology>
    <Distribution>virtual</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer></Manufacturer>
    <Manufacture-Protocol>
    </Manufacture-Protocol>
    <Contact-Ref ref="contrib2" />
  </Platform>

  <Sample iid="GSM3739076">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_1_RNA</Title>
    <Accession database="GEO">GSM3739076</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample , total RNA, replicate1
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739076/suppl/GSM3739076_WT_1_RNA_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532637" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766762" />
  </Sample>

  <Sample iid="GSM3739077">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_2_RNA</Title>
    <Accession database="GEO">GSM3739077</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample , total RNA, replicate2
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739077/suppl/GSM3739077_WT_2_RNA_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532636" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766763" />
  </Sample>

  <Sample iid="GSM3739078">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_3_RNA</Title>
    <Accession database="GEO">GSM3739078</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample , total RNA, replicate3
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739078/suppl/GSM3739078_WT_3_RNA_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532635" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766764" />
  </Sample>

  <Sample iid="GSM3739079">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_4_RNA</Title>
    <Accession database="GEO">GSM3739079</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample , total RNA, replicate4
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739079/suppl/GSM3739079_WT_4_RNA_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532634" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766765" />
  </Sample>

  <Sample iid="GSM3739080">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_5_RNA</Title>
    <Accession database="GEO">GSM3739080</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample , total RNA, replicate5
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739080/suppl/GSM3739080_WT_5_RNA_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532633" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766766" />
  </Sample>

  <Sample iid="GSM3739081">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_1_RP</Title>
    <Accession database="GEO">GSM3739081</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample, Ribosome bound RNA, replicate1
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739081/suppl/GSM3739081_WT_1_RP_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532632" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766767" />
  </Sample>

  <Sample iid="GSM3739082">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_2_RP</Title>
    <Accession database="GEO">GSM3739082</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample, Ribosome bound RNA, replicate2
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739082/suppl/GSM3739082_WT_2_RP_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532631" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766768" />
  </Sample>

  <Sample iid="GSM3739083">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_3_RP</Title>
    <Accession database="GEO">GSM3739083</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample, Ribosome bound RNA, replicate3
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739083/suppl/GSM3739083_WT_3_RP_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532630" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766769" />
  </Sample>

  <Sample iid="GSM3739084">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_4_RP</Title>
    <Accession database="GEO">GSM3739084</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample, Ribosome bound RNA, replicate4
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739084/suppl/GSM3739084_WT_4_RP_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532629" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766770" />
  </Sample>

  <Sample iid="GSM3739085">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-18</Last-Update-Date>
    </Status>
    <Title>WT_5_RP</Title>
    <Accession database="GEO">GSM3739085</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Normal prostate tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
Normal prostate
      </Characteristics>
      <Characteristics tag="genotype/variation">
wild type/ normal
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Wild type sample, Ribosome bound RNA, replicate5
    </Description>
    <Data-Processing>
Library strategy: Ribo-Seq
Library strategy: Ribo-Seq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and  employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3739nnn/GSM3739085/suppl/GSM3739085_WT_5_RP_htseq.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN11532628" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX5766771" />
  </Sample>

  <Sample iid="GSM4504137">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 78 Tumor sample, total RNA, replicate1</Title>
    <Accession database="GEO">GSM4504137</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 78 Tumor sample, total RNA, replicate1
LUCAP_78_RNA_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504137/suppl/GSM4504137_LUCAP_1_RNA_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755292" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190757" />
  </Sample>

  <Sample iid="GSM4504138">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 78 Tumor sample, total RNA, replicate2</Title>
    <Accession database="GEO">GSM4504138</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 78 Tumor sample, total RNA, replicate2
LUCAP_78_RNA_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504138/suppl/GSM4504138_LUCAP_1_RNA_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755291" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190758" />
  </Sample>

  <Sample iid="GSM4504139">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 78 Tumor sample, Ribosome bound RNA, replicate1</Title>
    <Accession database="GEO">GSM4504139</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 78 Tumor sample, Ribosome bound RNA, replicate1
LUCAP_78_RP_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504139/suppl/GSM4504139_LUCAP_1_RP_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755290" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190759" />
  </Sample>

  <Sample iid="GSM4504140">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 78 Tumor sample, Ribosome bound RNA, replicate2</Title>
    <Accession database="GEO">GSM4504140</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 78 Tumor sample, Ribosome bound RNA, replicate2
LUCAP_78_RP_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504140/suppl/GSM4504140_LUCAP_1_RP_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755289" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190760" />
  </Sample>

  <Sample iid="GSM4504141">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 81 Tumor sample, total RNA, replicate1</Title>
    <Accession database="GEO">GSM4504141</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 81 Tumor sample, total RNA, replicate1
LUCAP_81_RNA_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504141/suppl/GSM4504141_LUCAP_2_RNA_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755288" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190761" />
  </Sample>

  <Sample iid="GSM4504142">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 81 Tumor sample, total RNA, replicate2</Title>
    <Accession database="GEO">GSM4504142</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 81 Tumor sample, total RNA, replicate2
LUCAP_81_RNA_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504142/suppl/GSM4504142_LUCAP_2_RNA_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755287" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190762" />
  </Sample>

  <Sample iid="GSM4504143">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 81 Tumor sample, Ribosome bound RNA, replicate1</Title>
    <Accession database="GEO">GSM4504143</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 81 Tumor sample, Ribosome bound RNA, replicate1
LUCAP_81_RP_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504143/suppl/GSM4504143_LUCAP_2_RP_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755286" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190763" />
  </Sample>

  <Sample iid="GSM4504144">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 81 Tumor sample, Ribosome bound RNA, replicate2</Title>
    <Accession database="GEO">GSM4504144</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 81 Tumor sample, Ribosome bound RNA, replicate2
LUCAP_81_RP_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504144/suppl/GSM4504144_LUCAP_2_RP_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755285" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190764" />
  </Sample>

  <Sample iid="GSM4504145">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 92 Tumor sample, total RNA, replicate1</Title>
    <Accession database="GEO">GSM4504145</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 92 Tumor sample, total RNA, replicate1
LUCAP_92_RNA_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504145/suppl/GSM4504145_LUCAP_3_RNA_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755284" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190765" />
  </Sample>

  <Sample iid="GSM4504146">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 92 Tumor sample, total RNA, replicate2</Title>
    <Accession database="GEO">GSM4504146</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 92 Tumor sample, total RNA, replicate2
LUCAP_92_RNA_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504146/suppl/GSM4504146_LUCAP_3_RNA_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755282" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190766" />
  </Sample>

  <Sample iid="GSM4504147">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 92 Tumor sample, Ribosome bound RNA, replicate1</Title>
    <Accession database="GEO">GSM4504147</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 92 Tumor sample, Ribosome bound RNA, replicate1
LUCAP_92_RP_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504147/suppl/GSM4504147_LUCAP_3_RP_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755281" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190767" />
  </Sample>

  <Sample iid="GSM4504148">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 92 Tumor sample, Ribosome bound RNA, replicate2</Title>
    <Accession database="GEO">GSM4504148</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 92 Tumor sample, Ribosome bound RNA, replicate2
LUCAP_92_RP_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504148/suppl/GSM4504148_LUCAP_3_RP_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755278" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190768" />
  </Sample>

  <Sample iid="GSM4504149">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 145 Tumor sample, total RNA, replicate1</Title>
    <Accession database="GEO">GSM4504149</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 145 Tumor sample, total RNA, replicate1
LUCAP_145_RNA_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504149/suppl/GSM4504149_LUCAP_4_RNA_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755276" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190769" />
  </Sample>

  <Sample iid="GSM4504150">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 145 Tumor sample, total RNA, replicate2</Title>
    <Accession database="GEO">GSM4504150</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
total RNA
Lucap 145 Tumor sample, total RNA, replicate2
LUCAP_145_RNA_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504150/suppl/GSM4504150_LUCAP_4_RNA_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755275" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190770" />
  </Sample>

  <Sample iid="GSM4504151">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 145 Tumor sample, Ribosome bound RNA, replicate1</Title>
    <Accession database="GEO">GSM4504151</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 145 Tumor sample, Ribosome bound RNA, replicate1
LUCAP_145_RP_rep1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504151/suppl/GSM4504151_LUCAP_4_RP_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755273" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190771" />
  </Sample>

  <Sample iid="GSM4504152">
    <Status database="GEO">
      <Submission-Date>2020-04-28</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-05-17</Last-Update-Date>
    </Status>
    <Title>Lucap 145 Tumor sample, Ribosome bound RNA, replicate2</Title>
    <Accession database="GEO">GSM4504152</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 145 Tumor sample, Ribosome bound RNA, replicate2
LUCAP_145_RP_rep2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4504nnn/GSM4504152/suppl/GSM4504152_LUCAP_4_RP_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN14755272" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX8190772" />
  </Sample>

  <Sample iid="GSM5321286">
    <Status database="GEO">
      <Submission-Date>2021-05-18</Submission-Date>
      <Release-Date>2021-05-18</Release-Date>
      <Last-Update-Date>2021-05-19</Last-Update-Date>
    </Status>
    <Title>Lucap 147 Tumor sample, total RNA, replicate1</Title>
    <Accession database="GEO">GSM5321286</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Lucap 147 Tumor sample, total RNA, replicate1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5321nnn/GSM5321286/suppl/GSM5321286_lucap147_rna_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN19243571" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX10921844" />
  </Sample>

  <Sample iid="GSM5321287">
    <Status database="GEO">
      <Submission-Date>2021-05-18</Submission-Date>
      <Release-Date>2021-05-18</Release-Date>
      <Last-Update-Date>2021-05-19</Last-Update-Date>
    </Status>
    <Title>Lucap 147 Tumor sample, total RNA, replicate2</Title>
    <Accession database="GEO">GSM5321287</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
Lucap 147 Tumor sample, total RNA, replicate2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5321nnn/GSM5321287/suppl/GSM5321287_lucap147_rna_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN19243570" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX10921845" />
  </Sample>

  <Sample iid="GSM5321288">
    <Status database="GEO">
      <Submission-Date>2021-05-18</Submission-Date>
      <Release-Date>2021-05-18</Release-Date>
      <Last-Update-Date>2021-05-19</Last-Update-Date>
    </Status>
    <Title>Lucap 147 Tumor sample, Ribosome bound RNA, replicate1</Title>
    <Accession database="GEO">GSM5321288</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 147 Tumor sample, Ribosome bound RNA, replicate1
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5321nnn/GSM5321288/suppl/GSM5321288_lucap147_rp_rep1.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN19243569" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX10921846" />
  </Sample>

  <Sample iid="GSM5321289">
    <Status database="GEO">
      <Submission-Date>2021-05-18</Submission-Date>
      <Release-Date>2021-05-18</Release-Date>
      <Last-Update-Date>2021-05-19</Last-Update-Date>
    </Status>
    <Title>Lucap 147 Tumor sample, Ribosome bound RNA, replicate2</Title>
    <Accession database="GEO">GSM5321289</Accession>
    <Type>SRA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Prostate cancer tissue</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tissue">
tumor sample
      </Characteristics>
      <Growth-Protocol>
Tissues were obtained as frozen chunks, and manually pulverized before lysis
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA and ribosome-protected RNA were extracted following the protocol in the TruSeq Ribo Profile kit from Illumina
RNA libraries were prepared for sequencing following the protocol in the TruSeq Ribo Profile kit from Illumina
      </Extract-Protocol>
    </Channel>
    <Description>
RPF RNA
Lucap 147 Tumor sample, Ribosome bound RNA, replicate2
    </Description>
    <Data-Processing>
Library strategy: RiboSeq
Sequencing was performed using an Illumina HiSeq 2500 in Rapid Run mode and employed a single-end, 50 base read length (SE50) sequencing strategy.
RNA-seq reads were aligned to the UCSC hg19 assembly using Tophat2 and counted for gene associations against the UCSC genes database with HTSeq
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include raw values for each Sample.
    </Data-Processing>
    <Platform-Ref ref="GPL16791" />
    <Library-Strategy>OTHER</Library-Strategy>
    <Library-Source>transcriptomic</Library-Source>
    <Library-Selection>other</Library-Selection>
    <Instrument-Model>
      <Predefined>Illumina HiSeq 2500</Predefined>
    </Instrument-Model>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM5321nnn/GSM5321289/suppl/GSM5321289_lucap147_rp_rep2.txt.gz
    </Supplementary-Data>
    <Relation type="BioSample" target="https://www.ncbi.nlm.nih.gov/biosample/SAMN19243568" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRX10921847" />
  </Sample>

  <Series iid="GSE130465">
    <Status database="GEO">
      <Submission-Date>2019-04-29</Submission-Date>
      <Release-Date>2021-05-17</Release-Date>
      <Last-Update-Date>2021-07-27</Last-Update-Date>
    </Status>
    <Title>Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (Ribosome Profiling)</Title>
    <Accession database="GEO">GSE130465</Accession>
    <Pubmed-ID>34244513</Pubmed-ID>
    <Summary>
The functional consequences of cancer patient-derived genetic variants within the 5 untranslated regions (UTRs) on a genome-wide scale and their effects on mRNA transcript and translation levels are poorly understood. To systematically interrogate the mutational landscape of 5 UTRs across cancer patients with localized to metastatic disease, we analyzed the genomes of 226 prostate cancer patients and observed thousands of mutations, many of which impact known cis-regulatory elements. We developed a high-throughput multi-layer massively parallel sequencing-based method called PLUMAGE (Pooled full-length UTR Multiplex Assay on Gene Expression) to simultaneously quantify the effects of 545 5 UTR somatic mutations across recurrently mutated or cancer-related genes from our patient cohort. Our method enabled unprecedented insights into how 5 UTR mutations can control multiple levels of gene expression simultaneously. In particular, we identified 190 mutations that significantly altered 5 UTR function, either by creating new DNA binding elements, disrupting known translation regulatory motifs, or simultaneously impacting both transcript levels and mRNA translation. Furthermore, we also determined that 5 UTR mutations to the MAP kinase signaling pathway are significantly associated with early metastasis. This study is the first to comprehensively interrogate the functional 5 UTR mutational landscape of a human cancer revealing the importance of untranslated regions in regulating multiple levels of oncogenic gene expression and provides a high-throughput functional genomics solution applicable to many genetically driven diseases.
    </Summary>
    <Overall-Design>
To investigate the functional impact of 5 UTR mutations in advanced prostate cancer, we will conduct whole exome sequencing utilizing new 5 UTR exon capture technology on a cohort of end stage castration resistant prostate cancer patient derived xenografts (PDXs). Derived from rapid autopsy specimens, these PDX models have never been cultured, faithfully recapitulate human disease, and represent a nearly inexhaustible supply of tissues for biological replicates. A number of 5 UTR somatic mutations, insertions, and deletions were identified. To directly correlate these findings with the translation of specific transcripts genome-wide, we will perform ribosome profiling on biological replicates of the same PDXs. Normal human prostate tissue will also be profiled as a comparison to expression in prostate cancer. This will be the very first functional analysis of the 5 UTR regulome in a human cancer.
    </Overall-Design>
    <Type>Expression profiling by high throughput sequencing</Type>
    <Type>Other</Type>
    <Contributor-Ref ref="contrib3" position="1" />
    <Contributor-Ref ref="contrib1" position="2" />
    <Contributor-Ref ref="contrib4" position="3" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM3739076" />
    <Sample-Ref ref="GSM3739077" />
    <Sample-Ref ref="GSM3739078" />
    <Sample-Ref ref="GSM3739079" />
    <Sample-Ref ref="GSM3739080" />
    <Sample-Ref ref="GSM3739081" />
    <Sample-Ref ref="GSM3739082" />
    <Sample-Ref ref="GSM3739083" />
    <Sample-Ref ref="GSM3739084" />
    <Sample-Ref ref="GSM3739085" />
    <Sample-Ref ref="GSM4504137" />
    <Sample-Ref ref="GSM4504138" />
    <Sample-Ref ref="GSM4504139" />
    <Sample-Ref ref="GSM4504140" />
    <Sample-Ref ref="GSM4504141" />
    <Sample-Ref ref="GSM4504142" />
    <Sample-Ref ref="GSM4504143" />
    <Sample-Ref ref="GSM4504144" />
    <Sample-Ref ref="GSM4504145" />
    <Sample-Ref ref="GSM4504146" />
    <Sample-Ref ref="GSM4504147" />
    <Sample-Ref ref="GSM4504148" />
    <Sample-Ref ref="GSM4504149" />
    <Sample-Ref ref="GSM4504150" />
    <Sample-Ref ref="GSM4504151" />
    <Sample-Ref ref="GSM4504152" />
    <Sample-Ref ref="GSM5321286" />
    <Sample-Ref ref="GSM5321287" />
    <Sample-Ref ref="GSM5321288" />
    <Sample-Ref ref="GSM5321289" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE130nnn/GSE130465/suppl/GSE130465_RAW.tar
    </Supplementary-Data>
    <Relation type="SubSeries of" target="GSE149489" />
    <Relation type="BioProject" target="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA540298" />
    <Relation type="SRA" target="https://www.ncbi.nlm.nih.gov/sra?term=SRP194188" />
  </Series>

</MINiML>
